Objective: Patients with lung cancer patients report a worse quality of life than other cancer patients. Telenursing interventions should represent effective solutions in their clinical pathways. The study aims to provide an overview of telenursing interventions in lung cancer patients on chemotherapy.
Materials and Methods: A systematic review following the PRISMA Statement was performed. The following databases were consulted: PubMed, EMBASE, Cochrane Library, and CINAHL. The quality of the studies includ- ed was assessed through the GRADE method. Primary quantitative, qualitative, and mixed-method studies on telenursing intervention in lung cancer patients ≥ 18 years old, on chemotherapy, and in home-setting care were included (International Prospective Registry of Systematic Reviews Protocol ID: CRD42022332779).
Results: From the 801 studies retrieved, three were finally included in the review and resumed in a narrative synthesis.
Conclusions: Despite the increase in telenursing interventions during the pandemic, limited evidence was found in lung cancer patients on chemotherapy. The little evidence identified does not allow for drawing conclusive con- clusions regarding effectiveness, usability, and satisfaction with the care provided, either in addition to or as an alternative to usual care. Telenursing interventions and the perceived satisfaction of patients with lung cancer are potentially consistent and should improve access and quality of care, healthcare costs and resources.
To cite this article
Telenursing interventions in lung cancer patients on chemotherapy: a systematic review
Submission date: 11 Oct 2023
Revised on: 27 Nov 2023
Accepted on: 18 Jan 2024
Published online: 12 Feb 2024
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.